@phdthesis{Brasche2019,
  author    = {Brasche, Juliane},
  title     = {Patienten- und Anwenderfreundlichkeit des Safeguard-Druckverbandes im Vergleich zum ET-Druckverband (N{\"u}rnberger Ufo) zur Blutstillung nach transfemoralem Zugang : Studie},
  doi       = {10.25972/OPUS-18092},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-180921},
  school      = {Universit{\"a}t W{\"u}rzburg},
  year      = {2019},
  abstract  = {Ziel der Arbeit war der Vergleich von zwei Druckverbandsystemen in Hinblick auf effektive Blutstillung, Patienten- sowie Anwenderfreundlichkeit. Dazu wurden 117 Patienten, die sich zwischen M{\"a}rz 2011 und Dezember 2012 im Klinikum Fulda einer diagnostischen Angiographie unterzogen, in einer randomisierten offenen klinisch kontrollierten Studie untersucht. Die in der Studie untersuchten Druckverb{\"a}nde stellten sich als gleich sicher und effektiv bei der Blutstillung heraus. Es traten in der gesamten Studienpopulation keine schwergradigen Komplikationen auf. Der Safeguard-Druckverband l{\"a}sst sich leichter und schneller anbringen und entfernen, als der mit elastischen Binden fixierte ET-Druckverband. Er wurde zudem durch die Patienten besser toleriert und als bequemer empfunden. Zusammenfassend ist der Safeguard-Druckverband nach unkomplizierten diagnostischen Angiographien ebenso sicher, wie der UFO-Druckverband und zeigte dar{\"u}ber hinaus eine h{\"o}here Anwender- und Patientenfreundlichkeit.},
  subject      = {Druckverband},
  language  = {de}
}
@article{AsterEvdokimovBraunetal.2022,
  author    = {Aster, H-C and Evdokimov, D. and Braun, A. and {\"U}{\c{c}}eyler, N. and Sommer, C.},
  title     = {Analgesic Medication in Fibromyalgia Patients: A Cross-Sectional Study},
  series = {Pain Research and Management},
  volume    = {2022},
  journal   = {Pain Research and Management},
  doi       = {10.1155/2022/1217717},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-300578},
  year      = {2022},
  abstract  = {There is no approved drug for fibromyalgia syndrome (FMS) in Europe. In the German S3 guideline, amitriptyline, duloxetine, and pregabalin are recommended for temporary use. The aim of this study was to cross-sectionally investigate the current practice of medication in FMS patients in Germany. We systematically interviewed 156 patients with FMS, while they were participating in a larger study. The patients had been stratified into subgroups with and without a decrease in intraepidermal nerve fiber density. The drugs most commonly used to treat FMS pain were nonsteroidal anti-inflammatory drugs (NSAIDs) (41.0\% of all patients), metamizole (22.4\%), and amitriptyline (12.8\%). The most frequent analgesic treatment regimen was "on demand" (53.9\%), during pain attacks, while 35.1\% of the drugs were administered daily and the remaining in other regimens. Median pain relief as self-rated by the patients on a numerical rating scale (0-10) was 2 points for NSAIDS, 2 for metamizole, and 1 for amitriptyline. Drugs that were discontinued due to lack of efficacy rather than side effects were acetaminophen, flupirtine, and selective serotonin reuptake inhibitors. Reduction in pain severity was best achieved by NSAIDs and metamizole. Our hypothesis that a decrease in intraepidermal nerve fiber density might represent a neuropathic subtype of FMS, which would be associated with better effectiveness of drugs targeting neuropathic pain, could not be confirmed in this cohort. Many FMS patients take "on-demand" medication that is not in line with current guidelines. More randomized clinical trials are needed to assess drug effects in FMS subgroups.},
  language  = {en}
}
@misc{OPUS4-4266,
  title     = {UniZeit - Studieren an der Uni W{\"u}rzburg 2010/11},
  organization    = {Julius-Maximilians-Universit{\"a}t W{\"u}rzburg},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-51766},
  year      = {2010},
  abstract  = {UniZeit - Sch{\"u}lerzeitung der Julius-Maximilians-Universit{\"a}t W{\"u}rzburg 2010/11 Inhalts{\"u}bersicht: - Sprache, Kultur, Medien - Ingenieurwissenschaften - Mathe und Informatik - Naturwissenschaften - Lebenswissenschaften - Erziehung und Gesellschaft - Recht und Wirtschaft - Nach der Vorlesung - Studienangebot - Weitere Informationen},
  subject      = {W{\"u}rzburg},
  language  = {de}
}